Unity Bio Ownership 2024 | Who Owns Unity Bio Now?
Institutional Ownership
1.66%
Insider Ownership
1.31%
Retail Ownership
97.03%
Institutional Holders
2.00
Unity Bio Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALYESKA INVESTMENT GROUP, L.P. | 13.54% | 0.02% | 1,286,000 | 1,286,000 | 100.00% | 2,096,180,000 | Mar 31, 2023 |
| ARCH VENTURE MANAGEMENT, LLC | 10.58% | 0.79% | 1,004,817 | - | - | 1,637,852,000 | Mar 31, 2023 |
| VANGUARD GROUP INC | 5.52% | - | 523,924 | 80,100 | 18.05% | 853,996,000 | Mar 31, 2023 |
| FMR LLC | 3.03% | - | 287,987 | -475,133 | -62.26% | 469,419,000 | Mar 31, 2023 |
| UBS OCONNOR LLC | 2.24% | 0.02% | 213,040 | - | - | 347,255,000,000 | Mar 31, 2023 |
| MAYO CLINIC | 1.66% | 0.21% | 157,198 | 157,198 | 100.00% | 256,233,000 | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.30% | - | 122,983 | 31,882 | 35.00% | 200,462,000 | Mar 31, 2023 |
| BLACKROCK INC. | 1.13% | - | 107,496 | 37,078 | 52.65% | 175,218,000 | Mar 31, 2023 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.99% | 0.00% | 93,597 | 17,697 | 23.32% | 153,000 | Mar 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | 0.82% | 0.00% | 77,471 | -13,700 | -15.03% | 126,000 | Mar 31, 2023 |
| LAURION CAPITAL MANAGEMENT LP | 0.74% | 0.00% | 70,000 | - | - | 114,100,000 | Mar 31, 2023 |
| DIMENSIONAL FUND ADVISORS LP | 0.72% | - | 67,899 | 37,473 | 123.16% | 110,675,000 | Mar 31, 2023 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.53% | 0.00% | 50,000 | -10,705 | -17.63% | 81,500,000 | Mar 31, 2023 |
| SIMPLEX TRADING, LLC | 0.52% | 0.00% | 49,700 | -516,600 | -91.22% | 81,000 | Mar 31, 2023 |
| FOUNDERS FUND V MANAGEMENT, LLC | 0.52% | 6.17% | 49,172 | -442,579 | -90.00% | 80,150,000 | Mar 31, 2023 |
| MORGAN STANLEY | 0.50% | - | 47,451 | 2,397 | 5.32% | 77,345,000 | Mar 31, 2023 |
| CERCANO MANAGEMENT LLC | 0.43% | 0.00% | 41,238 | - | - | 67,218,000 | Mar 31, 2023 |
| ALYESKA INVESTMENT GROUP, L.P. | 0.41% | 0.00% | 38,695 | -658,753 | -94.45% | 63,073,000 | Mar 31, 2023 |
| STATE STREET CORP | 0.40% | - | 38,164 | 13,300 | 53.49% | 62,207,000 | Mar 31, 2023 |
| WOLVERINE TRADING, LLC | 0.30% | 0.00% | 28,300 | 28,300 | 100.00% | 48,000 | Mar 31, 2023 |
Unity Bio's largest institutional shareholder is ALYESKA INVESTMENT GROUP, L.P., holding 13.54% of the company's total share outstanding, currently valued at $2.10B. The top 10 institutional shareholders own together 40.81% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| FOUNDERS FUND V MANAGEMENT, LLC | 0.52% | 6.17% | 49,172 | -442,579 | -90.00% | 80,150,000 | Mar 31, 2023 |
| ARCH VENTURE MANAGEMENT, LLC | 10.58% | 0.79% | 1,004,817 | - | - | 1,637,852,000 | Mar 31, 2023 |
| MAYO CLINIC | 1.66% | 0.21% | 157,198 | 157,198 | 100.00% | 256,233,000 | Mar 31, 2023 |
| ALYESKA INVESTMENT GROUP, L.P. | 13.54% | 0.02% | 1,286,000 | 1,286,000 | 100.00% | 2,096,180,000 | Mar 31, 2023 |
| UBS OCONNOR LLC | 2.24% | 0.02% | 213,040 | - | - | 347,255,000,000 | Mar 31, 2023 |
| ARETE WEALTH ADVISORS, LLC | 0.11% | 0.01% | 10,392 | - | - | 142,298,000,000 | Mar 31, 2023 |
| CERCANO MANAGEMENT LLC | 0.43% | 0.00% | 41,238 | - | - | 67,218,000 | Mar 31, 2023 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.53% | 0.00% | 50,000 | -10,705 | -17.63% | 81,500,000 | Mar 31, 2023 |
| JOHNSON MIDWEST FINANCIAL, LLC | 0.01% | 0.00% | 661 | - | - | 1,077,000 | Mar 31, 2023 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.99% | 0.00% | 93,597 | 17,697 | 23.32% | 153,000 | Mar 31, 2023 |
| LAURION CAPITAL MANAGEMENT LP | 0.74% | 0.00% | 70,000 | - | - | 114,100,000 | Mar 31, 2023 |
| ALYESKA INVESTMENT GROUP, L.P. | 0.41% | 0.00% | 38,695 | -658,753 | -94.45% | 63,073,000 | Mar 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | 0.82% | 0.00% | 77,471 | -13,700 | -15.03% | 126,000 | Mar 31, 2023 |
| TWO SIGMA INVESTMENTS, LP | 0.21% | 0.00% | 19,600 | 19,600 | 100.00% | 31,948,000 | Mar 31, 2023 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.26% | 0.00% | 24,512 | 8,499 | 53.08% | 39,000 | Mar 31, 2023 |
| CARMICHAEL HILL & ASSOCIATES, INC. | 0.00% | 0.00% | 100 | - | - | 163,000 | Mar 31, 2023 |
| WOLVERINE TRADING, LLC | 0.30% | 0.00% | 28,300 | 28,300 | 100.00% | 48,000 | Mar 31, 2023 |
| SIMPLEX TRADING, LLC | 0.52% | 0.00% | 49,700 | -516,600 | -91.22% | 81,000 | Mar 31, 2023 |
| CIBC ASSET MANAGEMENT INC | 0.11% | 0.00% | 10,634 | 10,634 | 100.00% | 17,333,000 | Mar 31, 2023 |
| ALLSQUARE WEALTH MANAGEMENT LLC | 0.00% | 0.00% | 55 | - | - | 90,000 | Mar 31, 2023 |
The largest Unity Bio shareholder by % of total assets is FOUNDERS FUND V MANAGEMENT, LLC. The company owns 49.17K shares of Unity Bio (UBX), representing 6.17% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALYESKA INVESTMENT GROUP, L.P. | 13.54% | 0.02% | 1,286,000 | 1,286,000 | 100.00% | 2,096,180,000 | Mar 31, 2023 |
| MAYO CLINIC | 1.66% | 0.21% | 157,198 | 157,198 | 100.00% | 256,233,000 | Mar 31, 2023 |
| VANGUARD GROUP INC | 5.52% | - | 523,924 | 80,100 | 18.05% | 853,996,000 | Mar 31, 2023 |
| DIMENSIONAL FUND ADVISORS LP | 0.72% | - | 67,899 | 37,473 | 123.16% | 110,675,000 | Mar 31, 2023 |
| BLACKROCK INC. | 1.13% | - | 107,496 | 37,078 | 52.65% | 175,218,000 | Mar 31, 2023 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.30% | - | 122,983 | 31,882 | 35.00% | 200,462,000 | Mar 31, 2023 |
| WOLVERINE TRADING, LLC | 0.30% | 0.00% | 28,300 | 28,300 | 100.00% | 48,000 | Mar 31, 2023 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.30% | - | 28,255 | 28,255 | 100.00% | 46,056,000 | Mar 31, 2023 |
| TWO SIGMA INVESTMENTS, LP | 0.21% | 0.00% | 19,600 | 19,600 | 100.00% | 31,948,000 | Mar 31, 2023 |
| EXODUSPOINT CAPITAL MANAGEMENT, LP | 0.99% | 0.00% | 93,597 | 17,697 | 23.32% | 153,000 | Mar 31, 2023 |
| STATE STREET CORP | 0.40% | - | 38,164 | 13,300 | 53.49% | 62,207,000 | Mar 31, 2023 |
| CITADEL ADVISORS LLC | 0.23% | - | 21,950 | 12,560 | 133.76% | 35,779,000 | Mar 31, 2023 |
| CIBC ASSET MANAGEMENT INC | 0.11% | 0.00% | 10,634 | 10,634 | 100.00% | 17,333,000 | Mar 31, 2023 |
| CITADEL ADVISORS LLC | 0.13% | - | 12,400 | 8,990 | 263.64% | 20,212,000 | Mar 31, 2023 |
| COMMONWEALTH EQUITY SERVICES, LLC | 0.26% | 0.00% | 24,512 | 8,499 | 53.08% | 39,000 | Mar 31, 2023 |
| SIMPLEX TRADING, LLC | 0.07% | - | 6,300 | 5,800 | 1160.00% | 10,000 | Mar 31, 2023 |
| SIMPLEX TRADING, LLC | 0.05% | - | 4,517 | 4,517 | 100.00% | 7,000 | Mar 31, 2023 |
| MORGAN STANLEY | 0.50% | - | 47,451 | 2,397 | 5.32% | 77,345,000 | Mar 31, 2023 |
| GROUP ONE TRADING, L.P. | 0.00% | - | 290 | 290 | 100.00% | 473,000 | Mar 31, 2023 |
| WEALTHPLAN PARTNERS, LLC | 0.00% | - | 10 | 10 | 100.00% | 16,000 | Mar 31, 2023 |
As of Mar 31 2023, Unity Bio's largest institutional buyer is ALYESKA INVESTMENT GROUP, L.P.. The company purchased 1.29M stocks of UBX, valued at $2.10B.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALYESKA INVESTMENT GROUP, L.P. | 0.41% | 0.00% | 38,695 | -658,753 | -94.45% | 63,073,000 | Mar 31, 2023 |
| SIMPLEX TRADING, LLC | 0.52% | 0.00% | 49,700 | -516,600 | -91.22% | 81,000 | Mar 31, 2023 |
| FMR LLC | 3.03% | - | 287,987 | -475,133 | -62.26% | 469,419,000 | Mar 31, 2023 |
| GROUP ONE TRADING, L.P. | 0.10% | 0.00% | 9,600 | -461,800 | -97.96% | 15,648,000 | Mar 31, 2023 |
| FOUNDERS FUND V MANAGEMENT, LLC | 0.52% | 6.17% | 49,172 | -442,579 | -90.00% | 80,150,000 | Mar 31, 2023 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | - | - | - | -380,800 | -100.00% | - | Mar 31, 2023 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | - | - | - | -250,000 | -100.00% | - | Mar 31, 2023 |
| 683 CAPITAL MANAGEMENT, LLC | - | - | - | -240,000 | -100.00% | - | Mar 31, 2023 |
| MAYO CLINIC | - | - | - | -157,198 | -100.00% | - | Mar 31, 2023 |
| CANTOR FITZGERALD, L. P. | - | - | - | -144,500 | -100.00% | - | Mar 31, 2023 |
| ACADIAN ASSET MANAGEMENT LLC | 0.08% | - | 7,667 | -97,021 | -92.68% | 11,000 | Mar 31, 2023 |
| CVI HOLDINGS, LLC | - | - | - | -74,100 | -100.00% | - | Mar 31, 2023 |
| PARKMAN HEALTHCARE PARTNERS LLC | - | - | - | -42,749 | -100.00% | - | Mar 31, 2023 |
| CITADEL ADVISORS LLC | 0.03% | - | 2,593 | -31,527 | -92.40% | 4,227,000 | Mar 31, 2023 |
| VIRTU FINANCIAL LLC | - | - | - | -20,155 | -100.00% | - | Mar 31, 2023 |
| BAILARD, INC. | - | - | - | -17,700 | -100.00% | - | Mar 31, 2023 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -16,546 | -100.00% | - | Mar 31, 2023 |
| SCHONFELD STRATEGIC ADVISORS LLC | - | - | - | -14,000 | -100.00% | - | Mar 31, 2023 |
| RENAISSANCE TECHNOLOGIES LLC | 0.82% | 0.00% | 77,471 | -13,700 | -15.03% | 126,000 | Mar 31, 2023 |
| JANE STREET GROUP, LLC | - | - | - | -13,460 | -100.00% | - | Mar 31, 2023 |
As of Mar 31 2023, Unity Bio's biggest institutional seller is ALYESKA INVESTMENT GROUP, L.P.. The company sold -0.66M shares of UBX, valued at $63.07M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ALYESKA INVESTMENT GROUP, L.P. | 13.54% | 0.02% | 1,286,000 | 1,286,000 | 100.00% | 2,096,180,000 | Mar 31, 2023 |
| MAYO CLINIC | 1.66% | 0.21% | 157,198 | 157,198 | 100.00% | 256,233,000 | Mar 31, 2023 |
| WOLVERINE TRADING, LLC | 0.30% | 0.00% | 28,300 | 28,300 | 100.00% | 48,000 | Mar 31, 2023 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.30% | - | 28,255 | 28,255 | 100.00% | 46,056,000 | Mar 31, 2023 |
| TWO SIGMA INVESTMENTS, LP | 0.21% | 0.00% | 19,600 | 19,600 | 100.00% | 31,948,000 | Mar 31, 2023 |
| CIBC ASSET MANAGEMENT INC | 0.11% | 0.00% | 10,634 | 10,634 | 100.00% | 17,333,000 | Mar 31, 2023 |
| SIMPLEX TRADING, LLC | 0.05% | - | 4,517 | 4,517 | 100.00% | 7,000 | Mar 31, 2023 |
| GROUP ONE TRADING, L.P. | 0.00% | - | 290 | 290 | 100.00% | 473,000 | Mar 31, 2023 |
| WEALTHPLAN PARTNERS, LLC | 0.00% | - | 10 | 10 | 100.00% | 16,000 | Mar 31, 2023 |
| WESTSIDE INVESTMENT MANAGEMENT, INC. | 0.00% | - | 10 | 10 | 100.00% | 16,000 | Mar 31, 2023 |
Unity Bio's largest new institutional shareholder by number of shares is ALYESKA INVESTMENT GROUP, L.P., purchased 1.29M shares, valued at $2.10B, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | - | - | - | -380,800 | -100.00% | - | Mar 31, 2023 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | - | - | - | -250,000 | -100.00% | - | Mar 31, 2023 |
| 683 CAPITAL MANAGEMENT, LLC | - | - | - | -240,000 | -100.00% | - | Mar 31, 2023 |
| MAYO CLINIC | - | - | - | -157,198 | -100.00% | - | Mar 31, 2023 |
| CANTOR FITZGERALD, L. P. | - | - | - | -144,500 | -100.00% | - | Mar 31, 2023 |
| CVI HOLDINGS, LLC | - | - | - | -74,100 | -100.00% | - | Mar 31, 2023 |
| PARKMAN HEALTHCARE PARTNERS LLC | - | - | - | -42,749 | -100.00% | - | Mar 31, 2023 |
| VIRTU FINANCIAL LLC | - | - | - | -20,155 | -100.00% | - | Mar 31, 2023 |
| BAILARD, INC. | - | - | - | -17,700 | -100.00% | - | Mar 31, 2023 |
| MILLENNIUM MANAGEMENT LLC | - | - | - | -16,546 | -100.00% | - | Mar 31, 2023 |
| SCHONFELD STRATEGIC ADVISORS LLC | - | - | - | -14,000 | -100.00% | - | Mar 31, 2023 |
| JANE STREET GROUP, LLC | - | - | - | -13,460 | -100.00% | - | Mar 31, 2023 |
| GROUP ONE TRADING, L.P. | - | - | - | -12,700 | -100.00% | - | Mar 31, 2023 |
| BELVEDERE TRADING LLC | - | - | - | -11,600 | -100.00% | - | Mar 31, 2023 |
| PRIME CAPITAL INVESTMENT ADVISORS, LLC | - | - | - | -11,420 | -100.00% | - | Mar 31, 2023 |
| TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -10,349 | -100.00% | - | Mar 31, 2023 |
| UBS GROUP AG | - | - | - | -8,004 | -100.00% | - | Mar 31, 2023 |
| ROYAL BANK OF CANADA | - | - | - | -338 | -100.00% | - | Mar 31, 2023 |
| FEDERATED HERMES, INC. | - | - | - | -205 | -100.00% | - | Mar 31, 2023 |
| ROSENBERG MATTHEW HAMILTON | - | - | - | -200 | -100.00% | - | Mar 31, 2023 |
| MONEY CONCEPTS CAPITAL CORP | - | - | - | -60 | -100.00% | - | Mar 31, 2023 |
| CORRADO ADVISORS, LLC | - | - | - | -58 | -100.00% | - | Mar 31, 2023 |
Unity Bio's largest sold out institutional shareholder by shares sold is SUSQUEHANNA INTERNATIONAL GROUP, LLP, sold -0.38M shares, valued at -, as of undefined.
Unity Bio Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| FIDELITY MT VERNON STREET TRUST | 0.14% | 4,106,954 | - | - | Feb 29, 2024 |
| BRIDGEWAY FUNDS INC | 0.05% | 107,050 | - | - | Mar 28, 2024 |
| ETFis Series Trust I | 0.03% | 44,703 | - | - | Jan 31, 2024 |
| SMALLCAP WORLD FUND INC | 0.03% | 1,835,000 | - | - | Mar 31, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.02% | 9,250 | - | - | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.02% | 433,473 | - | - | Feb 29, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 6,145 | - | - | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 4,331,194 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 55,684 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,868 | - | - | Mar 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 21,887 | - | - | Feb 29, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 223,800 | - | - | Feb 29, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 393,058 | - | - | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 45,951 | - | - | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 2,907 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 31,699 | - | - | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 10,511 | - | - | Mar 31, 2024 |
| Columbia Funds Variable Series Trust II | 0.00% | 18,160 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 72,900 | - | - | Jan 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 287 | - | - | Apr 30, 2021 |
| GPS Funds I | 0.00% | 2,876 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 16,486 | - | - | Mar 31, 2024 |
| OLD WESTBURY FUNDS INC | 0.00% | 67,344 | - | - | Jan 31, 2024 |
| OHIO NATIONAL FUND INC | 0.00% | 7,381 | - | - | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 132,336 | - | - | Feb 29, 2024 |
| Federated Hermes Global Allocation Fund | 0.00% | 1,537 | - | - | Feb 29, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 415 | - | - | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 17,700 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 18,827 | - | - | Mar 28, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 42,628 | - | - | Jan 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 4,595 | - | - | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 6,490 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 1,137 | - | - | Mar 31, 2024 |
| RBB FUND, INC. | 0.00% | 6,262 | - | - | Feb 29, 2024 |
| ProFunds | 0.00% | 769 | - | - | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 253,350 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 14,010 | - | - | Jan 31, 2024 |
| ETF Series Solutions | 0.00% | 1,260 | - | - | Jan 31, 2024 |
| VALIC Co I | 0.00% | 16,819 | - | - | Feb 29, 2024 |
| PGIM ETF TRUST | 0.00% | 3,811 | - | - | Feb 29, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 5,174 | - | - | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 114,896 | - | - | Feb 29, 2024 |
| HC CAPITAL TRUST | 0.00% | 1,802 | - | - | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 13,962 | - | - | Jan 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 6,035 | - | - | Mar 31, 2024 |
| Meeder Funds | 0.00% | 195 | - | - | Mar 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 43,162 | - | - | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 10,044 | - | - | Feb 29, 2024 |
| Dimensional ETF Trust | 0.00% | 13,752 | -25,967 | -65.38% | Jan 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 900 | - | - | Mar 28, 2024 |
| TIAA-CREF FUNDS | 0.00% | 90,993 | - | - | Mar 31, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 2,544 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 19,401 | - | - | Jan 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 412 | - | - | Feb 29, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,781 | - | - | Feb 29, 2024 |
| Brighthouse Funds Trust II | 0.00% | 14,678 | - | - | Mar 31, 2024 |
| Legg Mason Global Asset Management Trust | 0.00% | 100,000 | - | - | Jan 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 5,058 | - | - | Feb 29, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 29,600 | - | - | Mar 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 4,000 | - | - | Mar 31, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 30,141 | - | - | Dec 31, 2023 |
| iSHARES TRUST | 0.00% | 108,210 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 6,671 | - | - | Jan 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 7,493 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 1,444 | - | - | Jan 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 366 | - | - | Feb 29, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 1,629 | - | - | Jan 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 4,462 | - | - | Dec 31, 2023 |
| PACIFIC SELECT FUND | 0.00% | 14,999 | - | - | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 13,641 | - | - | Mar 31, 2024 |
| WisdomTree Trust | 0.00% | 4,406 | - | - | Feb 29, 2024 |
| Dimensional ETF Trust | 0.00% | 860 | - | - | Jan 31, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 567 | - | - | Mar 31, 2024 |
| Legg Mason Global Asset Management Trust | 0.00% | 10,000 | - | - | Jan 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 6,507 | - | - | Feb 29, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 4,476 | - | - | Mar 31, 2024 |
| BLACKROCK FUNDS | 0.00% | 3,431 | - | - | Mar 28, 2024 |
| John Hancock Funds II | 0.00% | 6,073 | - | - | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 783 | - | - | Mar 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 5,800 | - | - | Feb 29, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 16 | - | - | Jan 31, 2024 |
Unity Bio's largest mutual fund holder by % of total assets is "FIDELITY MT VERNON STREET TRUST", owning 4.11M shares, compromising 0.14% of its total assets.
Unity Bio Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 31 Dec, 22 | 2 | -96.67% |
| 30 Sep, 22 | 60 | -1.64% |
| 30 Jun, 22 | 61 | -8.96% |
| 31 Mar, 22 | 67 | -1.47% |
| 31 Dec, 21 | 68 | -15.00% |
| 30 Sep, 21 | 80 | -16.67% |
| 30 Jun, 21 | 96 | 6.67% |
| 31 Mar, 21 | 90 | 5.88% |
| 31 Dec, 20 | 85 | 1.19% |
| 30 Sep, 20 | 84 | - |
| 30 Jun, 20 | 84 | 13.51% |
| 31 Mar, 20 | 74 | -6.33% |
| 31 Dec, 19 | 79 | 25.40% |
| 30 Sep, 19 | 63 | 10.53% |
| 30 Jun, 19 | 57 | 1.79% |
| 31 Mar, 19 | 56 | 3.70% |
| 31 Dec, 18 | 54 | 28.57% |
| 30 Sep, 18 | 42 | 2.44% |
| 30 Jun, 18 | 41 | - |
| 31 Mar, 16 | 1 | - |
As of 31 Dec 22, 2 institutions are holding Unity Bio's shares, representing a decrease of -96.67% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 31 Dec, 22 | 157,398 | -99.68% |
| 30 Sep, 22 | 48,825,280 | 419.04% |
| 30 Jun, 22 | 9,406,828 | -25.40% |
| 31 Mar, 22 | 12,609,530 | -13.67% |
| 31 Dec, 21 | 14,606,896 | 6.23% |
| 30 Sep, 21 | 13,750,857 | -23.97% |
| 30 Jun, 21 | 18,086,133 | -10.94% |
| 31 Mar, 21 | 20,306,750 | -2.83% |
| 31 Dec, 20 | 20,898,362 | 6.13% |
| 30 Sep, 20 | 19,691,401 | -20.99% |
| 30 Jun, 20 | 24,921,365 | 13.79% |
| 31 Mar, 20 | 21,900,703 | 0.47% |
| 31 Dec, 19 | 21,798,419 | 33.42% |
| 30 Sep, 19 | 16,337,616 | -1.42% |
| 30 Jun, 19 | 16,572,679 | 1.10% |
| 31 Mar, 19 | 16,392,461 | 3.50% |
| 31 Dec, 18 | 15,838,785 | 24.24% |
| 30 Sep, 18 | 12,748,108 | -0.41% |
| 30 Jun, 18 | 12,800,023 | - |
| 31 Mar, 16 | 300 | - |
Unity Bio (UBX) has 157.40K shares outstanding as of 31 Dec 22, down -99.68% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 31 Dec, 22 | 1.66% | 0.00% |
| 30 Sep, 22 | 484.76% | 2.63% |
| 30 Jun, 22 | 135.84% | 0.39% |
| 31 Mar, 22 | 186.73% | 0.30% |
| 31 Dec, 21 | 248.62% | 0.40% |
| 30 Sep, 21 | 248.05% | 0.23% |
| 30 Jun, 21 | 329.68% | 0.23% |
| 31 Mar, 21 | 374.88% | 0.22% |
| 31 Dec, 20 | 410.86% | 0.29% |
| 30 Sep, 20 | 375.20% | 0.15% |
| 30 Jun, 20 | 501.85% | 0.24% |
| 31 Mar, 20 | 460.64% | 0.18% |
| 31 Dec, 19 | 499.68% | 0.35% |
| 30 Sep, 19 | 380.25% | 0.25% |
| 30 Jun, 19 | 390.47% | 0.26% |
| 31 Mar, 19 | 388.53% | 0.12% |
| 31 Dec, 18 | 560.27% | 0.58% |
| 30 Sep, 18 | 310.49% | 0.13% |
| 30 Jun, 18 | 486.72% | - |
| 31 Mar, 16 | 0.01% | - |
As of 31 Dec 22, Unity Bio is held by 1.66% institutional shareholders, representing a 0.00% growth compared to 30 Sep 22.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 31 Dec, 22 | 1 | -97.14% |
| 30 Sep, 22 | 35 | 29.63% |
| 30 Jun, 22 | 27 | 12.50% |
| 31 Mar, 22 | 24 | -35.14% |
| 31 Dec, 21 | 37 | 54.17% |
| 30 Sep, 21 | 24 | -44.19% |
| 30 Jun, 21 | 43 | 16.22% |
| 31 Mar, 21 | 37 | -27.45% |
| 31 Dec, 20 | 51 | 21.43% |
| 30 Sep, 20 | 42 | -19.23% |
| 30 Jun, 20 | 52 | 62.50% |
| 31 Mar, 20 | 32 | -41.82% |
| 31 Dec, 19 | 55 | 77.42% |
| 30 Sep, 19 | 31 | -16.22% |
| 30 Jun, 19 | 37 | 2.78% |
| 31 Mar, 19 | 36 | -10.00% |
| 31 Dec, 18 | 40 | 42.86% |
| 30 Sep, 18 | 28 | -31.71% |
| 30 Jun, 18 | 41 | - |
| 31 Mar, 16 | 1 | - |
1 institutional shareholders have increased their position in UBX stock as of 31 Dec 22 compared to 35 in the previous quarter (a -97.14% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 31 Dec, 22 | 1 | -87.50% |
| 30 Sep, 22 | 8 | -42.86% |
| 30 Jun, 22 | 14 | -30.00% |
| 31 Mar, 22 | 20 | 66.67% |
| 31 Dec, 21 | 12 | -57.14% |
| 30 Sep, 21 | 28 | 16.67% |
| 30 Jun, 21 | 24 | -7.69% |
| 31 Mar, 21 | 26 | 116.67% |
| 31 Dec, 20 | 12 | -50.00% |
| 30 Sep, 20 | 24 | 84.62% |
| 30 Jun, 20 | 13 | -45.83% |
| 31 Mar, 20 | 24 | 118.18% |
| 31 Dec, 19 | 11 | -38.89% |
| 30 Sep, 19 | 18 | 100.00% |
| 30 Jun, 19 | 9 | -18.18% |
| 31 Mar, 19 | 11 | 83.33% |
| 31 Dec, 18 | 6 | 20.00% |
| 30 Sep, 18 | 5 | - |
| 30 Jun, 18 | - | - |
| 31 Mar, 16 | - | - |
1 institutional shareholders have reduced their position in UBX stock as of 31 Dec 22 compared to 8 in the previous quarter (a -87.50% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 31 Dec, 22 | 2 | -96.67% | 157,398 | -99.68% | 1.66% | 0.00% | 1 | -97.14% | 1 | -87.50% |
| 30 Sep, 22 | 60 | -1.64% | 48,825,280 | 419.04% | 484.76% | 2.63% | 35 | 29.63% | 8 | -42.86% |
| 30 Jun, 22 | 61 | -8.96% | 9,406,828 | -25.40% | 135.84% | 0.39% | 27 | 12.50% | 14 | -30.00% |
| 31 Mar, 22 | 67 | -1.47% | 12,609,530 | -13.67% | 186.73% | 0.30% | 24 | -35.14% | 20 | 66.67% |
| 31 Dec, 21 | 68 | -15.00% | 14,606,896 | 6.23% | 248.62% | 0.40% | 37 | 54.17% | 12 | -57.14% |
| 30 Sep, 21 | 80 | -16.67% | 13,750,857 | -23.97% | 248.05% | 0.23% | 24 | -44.19% | 28 | 16.67% |
| 30 Jun, 21 | 96 | 6.67% | 18,086,133 | -10.94% | 329.68% | 0.23% | 43 | 16.22% | 24 | -7.69% |
| 31 Mar, 21 | 90 | 5.88% | 20,306,750 | -2.83% | 374.88% | 0.22% | 37 | -27.45% | 26 | 116.67% |
| 31 Dec, 20 | 85 | 1.19% | 20,898,362 | 6.13% | 410.86% | 0.29% | 51 | 21.43% | 12 | -50.00% |
| 30 Sep, 20 | 84 | - | 19,691,401 | -20.99% | 375.20% | 0.15% | 42 | -19.23% | 24 | 84.62% |
| 30 Jun, 20 | 84 | 13.51% | 24,921,365 | 13.79% | 501.85% | 0.24% | 52 | 62.50% | 13 | -45.83% |
| 31 Mar, 20 | 74 | -6.33% | 21,900,703 | 0.47% | 460.64% | 0.18% | 32 | -41.82% | 24 | 118.18% |
| 31 Dec, 19 | 79 | 25.40% | 21,798,419 | 33.42% | 499.68% | 0.35% | 55 | 77.42% | 11 | -38.89% |
| 30 Sep, 19 | 63 | 10.53% | 16,337,616 | -1.42% | 380.25% | 0.25% | 31 | -16.22% | 18 | 100.00% |
| 30 Jun, 19 | 57 | 1.79% | 16,572,679 | 1.10% | 390.47% | 0.26% | 37 | 2.78% | 9 | -18.18% |
| 31 Mar, 19 | 56 | 3.70% | 16,392,461 | 3.50% | 388.53% | 0.12% | 36 | -10.00% | 11 | 83.33% |
| 31 Dec, 18 | 54 | 28.57% | 15,838,785 | 24.24% | 560.27% | 0.58% | 40 | 42.86% | 6 | 20.00% |
| 30 Sep, 18 | 42 | 2.44% | 12,748,108 | -0.41% | 310.49% | 0.13% | 28 | -31.71% | 5 | - |
| 30 Jun, 18 | 41 | - | 12,800,023 | - | 486.72% | - | 41 | - | - | - |
| 31 Mar, 16 | 1 | - | 300 | - | 0.01% | - | 1 | - | - | - |
Unity Bio Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Unity Bio's stock was made by Nguyen Alexander Hieu on Aug 06 2024, selling 154 shares at $1.53 per share (valued at $235.62).
Unity Bio Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | 7 | 4 | 175.00% |
| Q1 2024 | 2 | 2 | 100.00% |
| Q4 2023 | - | 2 | - |
| Q3 2023 | - | 3 | - |
| Q2 2023 | 19 | 13 | 146.15% |
| Q1 2023 | - | 7 | - |
| Q4 2022 | 4 | 3 | 133.33% |
| Q3 2022 | - | 3 | - |
| Q2 2022 | 16 | 6 | 266.67% |
| Q1 2022 | 8 | 4 | 200.00% |
| Q4 2021 | - | 1 | - |
| Q2 2021 | 16 | 1 | 1600.00% |
| Q1 2021 | 4 | 2 | 200.00% |
| Q4 2020 | 1 | 4 | 25.00% |
| Q3 2020 | 6 | 1 | 600.00% |
| Q2 2020 | 9 | 6 | 150.00% |
| Q1 2020 | 15 | 1 | 1500.00% |
| Q4 2019 | - | - | - |
| Q3 2019 | 4 | - | - |
| Q2 2019 | 20 | 1 | 2000.00% |
7 total buy trades, and 4 total sell trades (buy/sell ratio of 1.75%) were made by Unity Bio's insiders, as of Q2 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q2 2024 | - | 4 | - |
| Q1 2024 | - | 2 | - |
| Q4 2023 | - | 2 | - |
| Q3 2023 | - | 3 | - |
| Q2 2023 | - | 4 | - |
| Q1 2023 | - | 7 | - |
| Q4 2022 | - | 3 | - |
| Q3 2022 | - | 3 | - |
| Q2 2022 | - | 3 | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | - | 1 | - |
| Q3 2020 | - | - | - |
| Q2 2020 | 1 | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | - | - | - |
| Q3 2019 | - | - | - |
| Q2 2019 | - | - | - |
As of Q2 2024, Insider owners conducted 0 open market buy trades and 4 open market sell trades of Unity Bio's stocks.
Unity Bio Peer Ownership
| Ticker | Company |
|---|---|
| NUVB | Nuvation Bio Inc. |
| NXTC | NextCure, Inc. |
| ENSC | Ensysce Biosciences, Inc. |
| HOOK | HOOKIPA Pharma Inc. |
| RNA | Avidity Biosciences, Inc. |
| NTLA | Intellia Therapeutics, Inc. |
| EDIT | Editas Medicine, Inc. |
| PRME | Prime Medicine, Inc. |
| VERV | Verve Therapeutics, Inc. |
| RXRX | Recursion Pharmaceuticals, Inc. |
| HRTX | Heron Therapeutics, Inc. |
| DRMA | Dermata Therapeutics, Inc. |
| CNTB | Connect Biopharma Holdings Limited |
| ABOS | Acumen Pharmaceuticals, Inc. |
| AVIR | Atea Pharmaceuticals, Inc. |
| WINT | Windtree Therapeutics, Inc. |
| OVID | Ovid Therapeutics Inc. |
| BEAM | Beam Therapeutics Inc. |
| NLTX | Neurogene Inc. |
| BXRX | Baudax Bio, Inc. |
| EXAI | Exscientia plc |
| FIXX | Q32 Bio Inc. |
UBX Ownership FAQ
Who Owns Unity Bio?
Unity Bio is owned by institutional shareholders (1.66%), insiders (1.31%), and public (97.03%). The largest institutional shareholder of Unity Bio is ALYESKA INVESTMENT GROUP, L.P. (13.54% of total shares) and the top mutual fund owner is FIDELITY MT VERNON STREET TRUST (0.14% of total shares).
Who are the major institutional shareholders of Unity Bio?
Unity Bio's major institutional shareholders are ALYESKA INVESTMENT GROUP, L.P., ARCH VENTURE MANAGEMENT, LLC, VANGUARD GROUP INC, FMR LLC, and UBS OCONNOR LLC. The top five shareholders own together 34.92% of the company's share outstanding.
How many Unity Bio shareholders are there?
As of Dec 2022, there are 2 institutional shareholders of Unity Bio.
What percentage of Unity Bio is owned by ALYESKA INVESTMENT GROUP, L.P?
ALYESKA INVESTMENT GROUP, L.P owns 1.29M shares of Unity Bio, representing 13.54% of the company's total shares outstanding, valued at $2.1B (as of Mar 2023).
What percentage of Unity Bio is owned by ARCH VENTURE MANAGEMENT, LLC?
As of Mar 2023, ARCH VENTURE MANAGEMENT, LLC holds 1M shares of Unity Bio (UBX), compromising 10.58% of the company, valued at $1.64B.
What percentage of Unity Bio is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC is the third largest holder of Unity Bio. The company owns 523.92K of the company's shares outstanding (worth $854M).